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ABSTRACT
Herein, we sought new or improved endoribonu-
cleases based on catalytic DNA molecules known
as deoxyribozymes. The current repertoire of RNA-
cleaving deoxyribozymes can cleave nearly all of the
16 possible dinucleotide junctions with rates of
at least 0.1/min, with the exception of pyrimidine–
pyrimidine (pyr–pyr) junctions, which are cleaved
1–3 orders of magnitude slower. We conducted
four separate in vitro selection experiments to
target each pyr–pyr dinucleotide combination (i.e.
CC, UC, CT and UT) within a chimeric RNA/DNA
substrate. We used a library of DNA molecules con-
taining only 20 random-sequence nucleotides, so
that all possible sequence permutations could be
sampled in each experiment. From a total of 245
clones, we identified 22 different sequence families,
of which 21 represented novel deoxyribozyme
motifs. The fastest deoxyribozymes exhibited kobs
values (single-turnover, intermolecular format) of
0.12/min, 0.04/min, 0.13/min and 0.15/min against
CC, UC, CT and UT junctions, respectively. These
values represent a 6- to 8-fold improvement for CC
and UC junctions, and a 1000- to 1600-fold improve-
ment for CT and UT junctions, compared to the best
rates reported previously under identical reaction
conditions. The same deoxyribozymes exhibited
»1000-fold lower activity against all RNA substrates,
but could potentially be improved through further
in vitro evolution and engineering.
INTRODUCTION
Deoxyribozymes (or DNAzymes) are enzymes made from
single-stranded DNA (1). Although they are yet to be
found in nature, many diﬀerent deoxyribozymes have
been made in laboratories through a process known as
in vitro selection (2). Enzymes made from DNA can
oﬀer several practical advantages over those made from
protein or RNA, including simplicity/convenience, greater
stability and lower production costs. RNA-cleaving
deoxyribozymes represent a very important class (3),
which has been used for a variety of purposes including
(i) biosensors (4–7), (ii) DNA computational elements
with Boolean logic functions (8,9), (iii) nanomachines
(10), (iv) antiviral or gene control agents (11–13) and (v)
the in vitro manipulation of RNA (14).
We are interested in understanding the functional limits
of DNA-mediated catalysis, using RNA-cleaving deoxy-
ribozymes as a model system. These eﬀorts should expand
their utility, and provide insight to better assess future
applicative potential. One speciﬁc question that we have
sought to answer is how many diﬀerent dinucleotide
junctions can be cleaved eﬃciently by RNA-cleaving
deoxyribozymes?
This is an important question because the ability to
eﬃciently cleave at any location in a given RNA molecule
would be very useful for RNA structural and/or modiﬁ-
cation studies. Furthermore, improved cleavage site ver-
satility would beneﬁt applications involving long
RNA molecules, which often possess higher order struc-
tures that can interfere with DNAzyme binding, and
therefore limit the number and types of susceptible
target sites (15).
We have previously established that all 16 dinucleotide
junctions are in fact susceptible to deoxyribozyme-
mediated cleavage (16), but eﬃcient cleavage of all junc-
tions has not been demonstrated. Existing RNA-cleaving
deoxyribozymes such as the 10-23 (17), bipartite (18) and
8-17 (19) serve as a standard baseline, to which activity
can be compared. These deoxyribozymes can achieve reac-
tion rates from  0.1 to 10/min for the cleavage of various
purine–purine, purine–pyrimidine and/or pyrimidine–
purine junctions (Table 1). However, comparable rates
for cleavage of any of the four diﬀerent pyrimidine–
pyrimidine (pyr–pyr) junctions have not been reported.
So far, only the 8-17 deoxyribozyme has conﬁrmed
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eral orders of lower magnitude (19).
We have hypothesized that (i) eﬃcient deoxyribozyme-
mediated cleavage of all four pyr–pyr junctions is possible,
and (ii) these deoxyribozymes can be isolated through a
focused in vitro selection eﬀort using a small (i.e. 20nt)
random library approach. These hypotheses are largely
motivated by the recent discovery that 8-17 can cleave
all 16 dinucleotide junctions (19), and diﬀerent sequence
variants can show diﬀerent dinucleotide selectivities.
Because only 4 of the 15nt that comprise the 8-17 catalytic
core are absolutely conserved, there may still be more
proﬁcient variants among the thousands of possible
sequence permutations. A small random-sequence library
would thereby ensure that all 8-17 sequence variations are
represented in the initial pool. The identiﬁcation of more
eﬃcient 8-17 sequence variants is an attractive prospect,
because it would avoid the time-consuming characteriza-
tion experiments that are often necessary before novel
motifs can be used productively.
Toward this end, we conducted four separate in vitro
selection experiments to target the four diﬀerent types of
chimeric (RNA/DNA) pyr–pyr junctions (i.e. CC, UC, CT
and UT). Two additional selection experiments were also
performed as controls, targeting AC and AT junctions, for
which small and eﬃcient RNA-cleaving deoxyribozymes
are known to exist.
MATERIALS AND METHODS
Oligonucleotides and reagents
Oligonucleotides were prepared by automated DNA
synthesis using cyanoethylphosphoramidite chemistry
(Integrated DNA Technologies; Mobix Central Facility,
McMaster University). Oligonucleotides were puriﬁed by
10% preparative denaturing (8M urea) polyacrylamide
gel electrophoresis (PAGE) and their concentrations
were determined by spectroscopic methods. Nucleoside
50-triphosphates, [g-
32P]ATP and [a-
32P]dGTP were pur-
chased from Perkin Elmer (Boston, MA, USA). T4 DNA
ligase and T4 polynucleotide kinase (PNK) were pur-
chased from MBI Fermentas (Burlington, ON, CAN).
Tth DNA polymerase was purchased from Biotools
(Madrid, Spain). All chemical reagents were purchased
from Sigma (Oakville, ON, CAN).
Invitro selection procedure
The library design and in vitro selection procedure are
illustrated in Figures 1A and 2, respectively.
Step 1 and 2. The full-length 73-nt library was con-
structed by splint-directed ligation of the 43-nt enzyme
domain to the 30-nt substrate domain. Each selection
experiment used the same enzyme domain, but diﬀerent
substrate domains and appropriate ligation splints (i.e.
22-nt DNA oligos complementary to adjacent regions
in both the substrate and enzyme domains). A total
of 1000pmol of 50-phosphorylated enzyme domain,
1100pmol of ligation splint, 1200pmol of substrate
Table 1. Reaction rates of various RNA-cleaving DNAzymes against
diﬀerent dinucleotide junctions
DNAzyme 10-23 Bipartite 8-17 Various
Reference 17 18 19 This work
Size (nt) 15 20 15 20
Dinucleotide
junction
GG 9.2
AG 0.0001 3.1
CG 0.63
UG 0.20
GA ND 3.4
AA 0.1 1.4
CA 0.0001 0.17
UA <0.0001 0.47
GC 0.10 0.36
AC 0.015 0.01 0.11
CC 0.019 0.12
UC 0.0047 0.04
GU/T 0.38 0.0037
AU/T 0.31 0.01 0.00089
CT 0.00014 0.13
UT 0.000095 0.15
All kobs (min
 1) values were determined under single-turnover condi-
tions in an intermolecular format. Reaction conditions for 10-23:
10mM MgCl2, pH 7.5, 378C, all-RNA substrate. Reaction conditions
for bipartite: 30mM MgCl2, pH 7.4, 238C, all-RNA substrate. Reac-
tion conditions for 8-17: 100mM KCl, 400mM NaCl, 7.5mM MgCl2,
7.5mM MnCl2, pH 7.0, 238C, chimeric RNA/DNA substrate. The 8-17
rates are derived from several diﬀerent 8-17 sequence variants. Reaction
conditions for various DNAzymes from this work: 100mM KCl,
400mM NaCl, 7.5mM MgCl2, 7.5mM MnCl2, pH 7.0, 238C, chimeric
RNA/DNA substrate. Size refers to the length of the catalytic core.
ND: no detectable cleavage activity. Blank squares indicate no reported
cleavage activity.
Figure 1. Library design. (A) Sequences of libraries and PCR primers.
Regions that diﬀer in sequence are highlighted by gray boxes, which
include the dinucleotide cleavage junction (denoted as rN–N in the
sense primer) and the ﬁve terminal nucleotides of the substrate
domain (denoted as NNNNN in the sense primer). It should be
noted that six diﬀerent sense primers were used to minimize PCR
cross-contamination, although only one is shown for simplicity. N20
refers to 20 random nucleotides, where N=A, G, C or T deoxyribo-
nucleotides. Sp18 refers to an 18-atom hexa-ethyleneglycol spacer.
(B) Two hypothetical secondary structure arrangements showing loca-
tion of preengineered base-pairing interactions between substrate and
enzyme domains. A 2-nt frameshift in base-pairing interactions on the
50-side of the cleavage junction is possible. The structure on the right
shows how an 8-17 motif might form.
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32P-labelled enzyme domain
were combined, supplemented with DEPC-H20 to a ﬁnal
volume of 85ml, and then heated at 908C for 1min. After
cooling at RT for 10min, 10mlo f1 0   T4 DNA ligase
buﬀer (manufacturer supplied) and 5ml of T4 DNA
ligase (5 Weiss units/ml) were added to initiate the reac-
tion. The ligation mixture was incubated at RT for 2h,
then ethanol precipitated, and puriﬁed by 10% denaturing
PAGE. The ﬁnal yield of the 73-nt ligation product was
 600pmol, which was used for the ﬁrst round of selection.
Therefore, on average  300 copies of every possible
sequence should have been represented in the initial pool.
Step 3. The RNA cleavage reaction was initiated by
adding a 2  selection buﬀer (200mM KCl, 800mM
NaCl, 15mM MgCl2, 15mM MnCl2, 100mM HEPES
pH 7.0 at 238C) to an equal volume of DEPC-H20i n
which the 73-nt library had been resuspended and pre-
heated (908C for 30s, followed by 10min cooling at
RT), to a ﬁnal concentration of  1mM. The reaction
was incubated at RT for a designated period of time,
quenched with the addition of EDTA (pH 8.0) to
30mM, and ethanol precipitated. In rounds 1–4, a
100min reaction time was used. In round 5, the popula-
tion was divided into three subpopulations and subjected
to 1, 10 and 100min reaction times. In rounds 6–9, reac-
tion times of 0.1, 1 and 10min were used. From rounds 5
to 8, the 1min subpopulation was used to seed the next
round of selection.
Step 4. The 58-nt cleavage product was puriﬁed by 10%
denaturing PAGE, excised from the gel and recovered by
ethanol precipitation.
Step 5. The cleavage product was PCR ampliﬁed in a
100ml reaction volume, containing 0.2mM of each
dNTP, 10mlo f1 0   PCR buﬀer (Biotools), 0.5mM each
of sense and antisense primers, 5U Tth DNA polymerase,
2mlo f5 0   SYBR green (Invitrogen, Burlington, ON,
CAN) and 20mCi of [a-
32P]dGTP. Reactions were con-
ducted on a Cepheid SmartCycler (Sunnyvale, CA,
USA) and monitored in real time using SYBR green as
the reporter. Each PCR cycle consisted of 948C for 30s,
508C for 45s and 728C for 40s. PCR ampliﬁcation rein-
troduces the substrate domain, via the sense primer which
contains the target ribonucleotide. The antisense primer
contains an internal 18-atom hexa-ethyleneglycol spacer
that blocks further DNA polymerization, leading to a
dsDNA product of unequal length.
Step 6. The 73-nt sense strand was separated from the
88-nt antisense strand by 10% denaturing PAGE, excised
from the gel and recovered by ethanol precipitation. Steps
3–6 were repeated for nine rounds.
Cloning and sequencing of selected DNA populations
Deoxyribozymes from the 100min subpopulation of
round 5, and the 10min subpopulation of round 9 were
cloned with the InsTAclone PCR cloning kit (Fermentas).
Approximately 60 clones from each selection experiment
were chosen at random and sequenced by Functional
Biosciences Inc. (Madison, WI, USA).
Kinetic analyses
All rates were determined under single turnover condi-
tions, in which a large excess of deoxyribozyme
( 1.7mM) was used with a trace amount of 50-
32P-labeled
substrate ( 0.002mM). Substrate and deoxyribozyme
were heated together at 908C for 30s and allowed to
cool at RT for  10min. An equal volume of 2  reaction
buﬀer (200mM KCl, 800mM NaCl, 15mM MgCl2,
15mM MnCl2, 100mM HEPES pH 7.0 at 238C) was
added to the deoxyribozyme/substrate mixture to initiate
the reaction. The reaction was terminated after a desig-
nated period of time by the addition of quenching buﬀer
containing 60mM EDTA, 7M urea and loading dye solu-
tion. The cleavage products from a reaction timecourse
Figure 2. In vitro selection scheme. Step 1 and 2: ligation of substrate
and enzyme domains, followed by PAGE puriﬁcation (ﬁrst round
only). Step 3: RNA cleavage reaction is conducted in presence of sui-
table buﬀer and designated period of time. Step 4: the 58-nt cleavage
product is separated from the 73-nt uncleaved precursor molecules.
Step 5: PCR ampliﬁcation. Sp18 refers to an 18-atom hexa-ethylenegly-
col spacer that blocks DNA polymerization, leading to a dsDNA pro-
duct composed of two strands of unequal length. The sense primer
contains the target ribonucleotide cleavage junction. Step 6: separation
of the 73-nt sense strand from the 88-nt antisense strand. Steps 3–6 are
then repeated to enrich the population for active sequences.
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tated using PhosphorImager and ImageQuant software.
A graph of fraction cleaved versus time was plotted for
each timecourse, and the experimental data ﬁt to a single
exponential equation Y=Ymax(1 e
( kobs t)) using non-
linear regression analysis in GraphPad Prism 4, from
which the observed rate constant (kobs) and maximum
cleavage yield (Ymax) were determined. Kinetic parameters
were determined from at least two independent experi-
ments that diﬀered by <30%.
Metal ion dependency
Simple assays based on single-timepoint measurements
were used to determine the relative activity of a given
deoxyribozyme under various ‘nonwild-type’ buﬀer condi-
tions. The same general reaction conditions and protocol
were used as described earlier; however, rates were
approximated using the equation kobs= ln(1 fraction
cleaved)/time. We have previously found that this
method provides a reasonable estimation of the rate,
when appropriate timepoints are chosen (i.e. prior to reac-
tion plateau). Therefore, any reactions that exceeded 75%
(typical reaction endpoints ranged from  75% to 90%)
cleavage product at an initial timepoint were subsequently
assayed with a shorter timepoint(s) for accuracy. The
amount of error incurred by this simpliﬁed assay is
small relative to the overall range of activity being
assayed, which spans several orders of magnitude. The
relative activity was calculated as knon-WT buﬀer/
kWT buﬀer. When necessary, slower reactions were followed
for at least 72h. If a distinct cleavage signal was not
observed in this period of time, the rate was assumed to
be the background rate of  10
 7/min.
RESULTS
Library design
Six independent in vitro selection experiments were con-
ducted in parallel using the library design illustrated in
Figure 1A. The substrate domain contains a single ribonu-
cleotide embedded in an otherwise all-DNA sequence.
Chimeric (RNA/DNA) substrates were used instead of
all-RNA substrates, so that speciﬁc dinucleotide junctions
could be unambiguously targeted. Whereas the phospho-
diester bonds in an all-RNA substrate are equally suscep-
tible to hydrolytic cleavage, the target ribonucleotide in a
chimeric substrate is  100000-fold more susceptible than
the surrounding deoxyribonucleotides (20). The four types
of pyr–pyr junctions (i.e. CC, UC, CT and UT) were our
primary targets of interest, because eﬃcient cleavage of
these junctions has not been demonstrated. However,
two additional selection experiments were also performed
as controls, targeting AC and AT junctions, for which
eﬃcient RNA-cleaving deoxyribozymes (i.e. bipartite and
8-17) are known to exist (Table 1). The recurrence of these
known RNA-cleaving deoxyribozymes would provide a
measure of conﬁdence in the eﬀectiveness of our selection
strategy and the reproducibility of our results.
The last ﬁve nucleotides at the 30-end of the substrate
domain diﬀered between experiments, in order to
minimize the possibility of cross-contamination during
PCR ampliﬁcation. The enzyme domain was designed
with 20 random sequence nucleotides. The length of this
random domain is not only short enough to cover all
sequence permutations for a typical 8-17 motif measuring
14–15nt, but also long enough to accommodate atypical
8-17 variants containing 1–2nt bulges/insertions. All selec-
tion experiments started with a library of  3 10
14 mole-
cules, so every possible sequence (i.e. 4
20 or  10
12
sequences) should be represented by  300 copies on aver-
age. Multiple copy representation of each sequence should
minimize the risk of losing deoxyribozymes through
random experimental losses. Substrate recognition arms
measuring 5 and 6bp in length were designed into the
sequence of the substrate and enzyme domains according
to the scheme shown in Figure 1B. These base-pairing
interactions are located several nucleotides downstream
and upstream from the cleavage site, to provide some ver-
satility in how potential deoxyribozymes engage the sub-
strate. For instance, an 8-17 motif (Figure 1B, right
structure) could use some of the excess random nucleotides
to form additional stabilizing base-pairs with the substrate.
Invitro selection strategy
The in vitro selection scheme used in this study is depicted
in Figure 2. In step 1, the sense primer (which serves as the
substrate domain) is ligated to the enzyme domain, fol-
lowed by PAGE puriﬁcation in step 2. In step 3, the 73-nt
full-length library molecules are incubated with the reac-
tion buﬀer (7.5mM MgCl2, 7.5mM MnCl2, 100mM KCl,
400mM NaCl, 50mM HEPES pH 7.0 at 238C) for a
designated period of time. In step 4, PAGE is used to
separate the 58-nt cleavage products from the uncleaved
precursor molecules. PCR ampliﬁcation is conducted in
step 5, which reintroduces the substrate domain via the
sense primer. The antisense primer contains an internal
18 atom spacer that cannot be extended by DNA poly-
merase, leading to a dsDNA product composed of two
strands of unequal length. In step 6, the 73-nt sense
strand (containing the ribonucleotide cleavage junction)
is separated from the 88-nt antisense strand through
PAGE. Steps 3–6 are then repeated to enrich the popula-
tion for functional deoxyribozyme sequences.
Selection progress
The percent cleavage product observed at each round of
selection is illustrated in Figure 3. A total of nine rounds
of selection were conducted in each experiment, and a
distinct cleavage product (from 5% to 40%) was ﬁrst
observed by round 4. During the ﬁrst four rounds of selec-
tion, a single reaction time of 100min was used. In sub-
sequent rounds, the selection stringency was increased by
reducing the reaction time, in an eﬀort to isolate the fast-
est deoxyribozymes within each population of sequences.
In round 5, the main population was divided into three
subpopulations that were subjected to 1, 10 and 100min
reaction times. Multiple reaction times were used to better
gauge the response/progress of each population to a given
time pressure. In rounds 6–9, reaction times of 0.1, 1 and
10min were used. However, no appreciable cleavage
Nucleic Acids Research, 2008, Vol. 36, No. 14 4771product was observed under the 0.1min reaction time in
any of the selection experiments. From rounds 5 to 9, the
1min subpopulation in each selection experiment was
used to seed (i.e. provide input molecules for) the next
round of selection. By round 9 (or earlier), the composite
population from each selection experiment could cleave its
target dinucleotide junction with a rate of  0.01–0.1/min.
All experiments were terminated at round 9 after no
appreciable increase in activity was observed for several
rounds.
Deoxyribozyme sequence diversity and distribution
Approximately 60 clones from each selection experiment
were randomly chosen for sequence analysis. Approxi-
mately half of these clones were taken from round 5
(100min subpopulation) and the other half were taken
from the terminal round 9 (10min subpopulation).
Clones from the 10min subpopulation of round 9 were
sequenced instead of the 1min subpopulation, in order
to minimize the likelihood of background contaminating
sequences due to the low level of cleavage observed in
some populations under the latter selection time.
Twenty-six diﬀerent sequence families were identiﬁed
in total, of which only 12 survived until round 9.
The number of sequence families per population varied
from 3 to 10, and several sequence families were identiﬁed
in two or three diﬀerent selection experiments. The fre-
quency and distribution of clones are summarized in
Figure 4. The sequences of all clones are available in Sup-
plementary Figure 1.
Recurrence of the8-17 motif
We identiﬁed 28 diﬀerent 8-17 sequence variants from 34
clones and grouped them into one sequence family (S24)
for simplicity. Based on previous characterization studies
(16,19,21), we have deﬁned an 8-17 motif by the presence
of four absolutely conserved bases and 4–6 co-varying
nucleotides that form a putative 2–3bp stem. The 8-17
variants were observed in the AC, CC and CT popula-
tions, with the majority (22 sequence variants from 27
clones) found in the AC population. Only three 8-17
sequence variants survived until round 9, and all were
found in the AC control selection experiment, consistent
with expectations. Eight sequence variants were chosen for
kinetic analysis in trans, under single-turnover conditions.
Three sequence variants from the round 9 AC population
exhibited comparable rates to the best NC-cleaving 8-17
variant (i.e. ‘8-17NC’) reported previously by our lab (19).
Figure 3. In vitro selection progress. The percent cleavage product is shown for each selection round. A 100min selection time was used for the ﬁrst
four rounds of selection. In round 5, the population from each selection experiment was divided into subpopulations and subjected to a 1, 10 or
100min selection time. In rounds 6–9, selection times of 0.1, 1 and 10min were imposed. Less than 1% cleavage product was observed in the 0.1min
subpopulations. From rounds 5–9, the 1min subpopulation from each selection experiment was used to seed each subsequent round of selection.
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was not isolated herein, but this is not surprising since
many sequence variants are known to be phenotypically
equivalent. The activities of two 8-17 sequence variants
from each of the CC and CT populations (round 5)
were also determined. Interestingly, while the rates of
three of these 8-17 variants were comparable to our pre-
vious report, one 8-17 variant (denoted as 8-17CT) actu-
ally exhibited a  1000-fold improvement with a rate of
0.13/min (Ymax=87%). The sequence and kinetic analysis
of 8-17CT is shown in Figure 5. The 8-17CT contains a
distorted stem (due to a mismatch in the central position),
and a tetra-loop instead of a tri-loop, which are features
also shared in common with 8-17NC described previously.
The 8-17 variants have been shown to exhibit robust
activity against groups of related dinucleotide junctions
(e.g. NG group, where N=G, A, C or U) rather than
any single junction. Contrary to expectations, however,
8-17CT was quite selective (from  25- to 100-fold) for a
CT junction over the related GT, AT and UT junctions
(Figure 5). The 8-17CT was also tested against GC, AC,
CC and UC junctions, but showed no activity in 100min
(data not shown).
Recurrence of thebipartite motif and identification
of novel deoxyribozymes
Consistent with expectations, we identiﬁed the bipartite
deoxyribozyme (S22) in both the AT and AC control
selection experiments. It should be noted that the 10-23
motif was not reisolated in either control experiment,
because it does not cleave chimeric substrates as proﬁ-
ciently as all-RNA substrates. The activity of 10-23
against chimeric substrates has not been previously
reported; therefore, we tested two diﬀerent 10-23 motifs
optimized for cleavage of either AC or AU junctions (17),
under our reaction conditions and with our chimeric AC
and AT substrates. Only 2 and 8% cleavage product was
observed in 100min against the AC and AT junctions,
respectively. These results indicate that the 10-23 deoxy-
ribozyme would not be competitive under the imposed
selection time pressure, and therefore unlikely to survive
multiple rounds of selection.
The remaining 10 sequence families identiﬁed in round 9
represent novel deoxyribozymes that have not been pre-
viously reported. A representative sequence from each
Figure 5. Characterization of the 8-17CT sequence variant. (A)
Sequence and proposed secondary structure. Underlined nucleotides
are absolutely conserved in the 8-17 motif and used to identify sequence
variants. (B) Reaction time course conducted under single-turnover
conditions. The kobs=0.13/min, Ymax=87%. Circles represent the
average value of duplicate trials, for which standard error bars are
smaller than circle diameter. Corresponding autoradiogram shows
increase in cleavage product (P) as a function of time. Cleavage pro-
ducts (P) were separated from uncleaved substrates (S) by 10% dena-
turing PAGE. (C) Cleavage site selectivity. Autoradiogram depicting
cleavage activity against CT, UT, GT and AT dinucleotide junctions.
Figure 4. Frequency and distribution of in vitro selected deoxyribo-
zymes. A total of 360 clones were sequenced and grouped into 26
diﬀerent sequence families. The number of clones in each sequence
family is shown, along with their distribution among the six selection
experiments. Each selection experiment is denoted by a speciﬁc dinu-
cleotide junction (AC, CC, UC, AT, CT or UT), and divided into
round 5 (R5) and round 9 (R9). S24 contains the 8-17 motif. S22
contains the bipartite motif.
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mation within the random-sequence domain of each
family appears limited, with contiguous base-pairing
up to 3bp (Supplementary Figure 2). The preengineered
substrate binding arms made for the facile separation of
substrate and enzyme domains into an intermolecular
format, which was further simpliﬁed with the removal of
excess sequence elements peripheral to the core region.
The random sequence domain also did not harbor any
strong sequence complementarity to the substrate that
might compete with the preengineered binding arms.
Each deoxyribozyme sequence was conﬁrmed to be
active in trans under single-turnover conditions against
their primary (i.e. most abundant) target dinucleotide
junction (Table 2). The reaction rate (kobs) varied from
0.007 to 0.15/min, with maximum cleavage yields (Ymax)
between 74% and 90%. From among these new sequence
families, deoxyribozymes S9, S4, S15 and S21 exhibited
the fastest kobs values against CC (0.12/min), UC
(0.04/min), CT (0.1/min) and UT (0.15/min) junctions,
respectively. In comparison to the fastest rates previously
reported and determined under identical reaction condi-
tions (Table 1), S9 and S4 provide a 6- to 8-fold improve-
ment, while S15 and S21 provide a 700- to 1600-fold
improvement.
Clones from several sequence families (including S3, S4,
S10, S20 and S22) were identiﬁed in two diﬀerent selection
experiments (Figure 4). The activity of each of these
sequence families was therefore veriﬁed against the rele-
vant secondary dinucleotide junction. Each family was
indeed active, but generally slower, by up to  20-fold in
some cases.
Metal iondependency
The ‘wild-type’ (WT) reaction buﬀer used during in vitro
selection contained several monovalent and divalent metal
ions including 100mM KCl, 400mM NaCl, 7.5mM
MgCl2 and 7.5mM MnCl2 (in 50mM HEPES pH 7.0).
The eﬀect of each buﬀer component on the activity of
the new deoxyribozymes was systematically examined
(Figure 6). Monovalent ions were generally unnecessary,
although the rate of three deoxyribozymes (S4-UC,
S10-UC and S20-UT) decreased by 10- to 100-fold when
both K
+ and Na
+ were removed. None of the deoxyri-
bozymes exhibited a strict dependence on Mg
2+. In con-
trast, a strong Mn
2+-dependency was observed for the
majority of deoxyribozymes including (S3-AC, S23-AT,
S9-CC, S13-CT, S15-CT, S19-CT, S4-UC and S21-UT),
which was reﬂected by a 10
2-t o1 0
6-fold decrease in activ-
ity upon Mn
2+ removal. In several cases (S22-AT,
S10-UC and S20-UT), the presence of either Mg
2+ or
Mn
2+ could support near WT levels of activity, although
Mn
2+ was always preferred by  10-fold. Interestingly, the
presence of monovalent ions alone could support some
level of activity (up to  100-fold) above background
for S4-UC, S10-UC and S20-UT. The S10-UC deoxyribo-
zyme exhibited a near WT level of activity (only  10-fold
less) in the presence of 2M NaCl. This deoxyribozyme
bears little sequence homology to the G3 metal-
independent deoxyribozymes reported by Sen and col-
leagues (22).
Cleavage activity against all-RNA substrates
The cleavage activity of each pyr–pyr cleaving deoxyribo-
zyme from Table 2 was evaluated against all-RNA sub-
strates, using the same reaction conditions and format
described previously. Each substrate was identical to
the substrate sequence shown in Table 2, except for the
addition of two G residues on the 50-end (to increase
RNA transcript yield). Deoxyribozymes S9, 8-17CT, S4,
S20 and S21 showed detectable but severely reduced
( 1000-fold lower) activity against all-RNA substrates
(Supplementary Figure 3). The remaining deoxyribozymes
did not show detectable cleavage activity within a 72h
time period.
Table 2. Sequence and rate constants of select deoxyriboyzmes
The kobs values represent the average of at least two independent trials, which diﬀered by <30%. Reactions
were conducted under single-turnover conditions in 100mM KCl, 400mM NaCl, 7.5mM MgCl2, 7.5mM
MnCl2, 50mM HEPES pH 7.0 at 238C. The underlined region of S22 is identical to the bipartite consensus
sequence, with exceptions denoted in boldface. The sequence of the substrate (sub.) is also provided, written 30
to 50 in opposite orientation. YrH represents the dinucleotide cleavage junction, where Y=C or T, and H=A,
Co rU .
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Herein, we have demonstrated that all four chimeric
RNA/DNA, pyr–pyr junctions, can be eﬃciently cleaved
by small deoxyribozymes. From a total of 245 deoxyribo-
zyme clones isolated in four separate in vitro selection
experiments, we identiﬁed 22 diﬀerent sequence families
that can cleave one or more pyr–pyr junctions. Twenty-
one of these sequence families have not been previously
described. The best deoxyribozymes (S9, S4, 8-17CT and
S21) can collectively cleave all four pyr–pyr junctions with
rates ranging from 0.04 to 0.15/min, which are  1–3
orders of magnitude faster than the best deoxyribozymes
reported previously (Table 1). From among 115 clones
isolated in two additional control experiments, targeting
AC and AT junctions, we identiﬁed seven diﬀerent deoxy-
ribozyme sequence families including variants of the 8-17
and bipartite motifs. The remaining ﬁve sequence families
represent novel motifs, but they do not provide any sig-
niﬁcant rate improvements over 8-17 or bipartite.
All of the deoxyribozymes isolated herein are 10- to
100-fold slower than other deoxyribozymes of comparable
size (Table 1) that catalyze the cleavage of purine–purine
junctions. Therefore, this study strengthens our previous
suggestion that pyr–pyr junctions may be inherently more
diﬃcult to cleave (16,19). We have speculated that base-
stacking interactions at the dinucleotide junction may play
an important role in the cleavage mechanism of small
deoxyribozymes, since purine bases can form stronger
stacking interactions than pyrimidine bases (23–25).
This study also provides new insight into the functional
versatility of the well known 8-17 deoxyribozyme. We
have previously speculated that the structure of this deo-
xyribozyme might be ﬂexible enough to support fast cleav-
age of all dinucleotide junctions, since only 4 of the 15
nucleotides that form its structural scaﬀold are catalyti-
cally essential. Because there are thousands of possible
sequence variations (with unknown functional implica-
tions), a systematic and comprehensive mutational analy-
sis would not be practical. However, by using a library
containing only 20 random-sequence positions, we were
able to sample every 20-nt sequence permutation in
each selection experiment, including all 8-17 sequence
variations. Consistent with expectations, we found 8-17
variants in the AC and CC populations that exhibited
comparable rates to those described previously. No
8-17 variants were found in the AT, UC or UT
Figure 6. Metal ion dependency of select deoxyribozymes. The sequence class and target dinucleotide junction is provided in each graph. Relative
activity=kMutant,buﬀer/kWT,buﬀer. WT buﬀer contains 100mM KCl, 400mM NaCl, 7.5mM MgCl2, 7.5mM MnCl2 (and 50mM HEPES pH 7.0 at
238C). Each metal ion was systematically removed individually, or in combination, as indicated above each graph. ‘Mn only’ refers to a buﬀer
containing only 7.5mM MnCl2. ‘2M Na only’ refers to a buﬀer containing only 2M NaCl.
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variant (8-17CT) in the CT population that was  1000-
fold faster than the best 8-17 variant previously reported
for the cleavage of this junction.
These results should be considered in the design of
future in vitro selection experiments. A substantial eﬀort
has been expended to search for new and more useful
RNA-cleaving deoxyribozymes, and in at least ﬁve inde-
pendent studies (16,26–30), the recurrence of 8-17 has
hampered this objective. Since UC and UT junctions are
the least susceptible to 8-17-mediated cleavage, these dinu-
cleotide junctions represent the best target cleavage sites to
search for novel motifs, using larger random sequence
domains. The likelihood of recurrence of other motifs
described herein will depend on several factors (31), but
in general, is expected to be lower due to the higher degree
of sequence conservation in their putative catalytic cores
(Supplementary Figure 1).
Limitations
It is important to recognize that the best possible solutions
to a given selection experiment (typically presumed to be
the most abundant sequences) might not always have the
desired target phenotype. For instance, we did not always
observe a direct correlation between the abundance of a
given clone and its catalytic rate, as in the case of S20 and
S21. Interestingly, S20 was about  20-fold more abun-
dant than S21, but  20-fold slower than S21, contrary
to expectations. This discrepancy may be due to the fact
that rates were determined using a simpliﬁed intermolecu-
lar format (in which some ﬁxed sequence regions were
removed), and therefore may not reﬂect the activities
of the full-length cis constructs that actually competed
during selection. We tested this possibility, and
determined that the activity of each full-length cis
construct (S21 kobs=0.056/min, Ymax=46%; S20
kobs=0.036/min, Ymax=22%) diﬀers from the activity
determined by the simpliﬁed intermolecular format
(Table 2). The diﬀerence in activity between the full-
length cis constructs ( 1.5-fold) is smaller than the diﬀer-
ence observed between the simpliﬁed trans constructs
( 20-fold); however, S21 still exhibits superior cleavage
activity, which does not readily explain the discrepancy
in their relative abundance.
Our previous study of in vitro selection population
dynamics has suggested how secondary ﬁtness constraints
imposed unintentionally on the population, can unpredic-
tably inﬂuence the relative abundance of diﬀerent catalytic
species (32). This scenario can enable sequences with non-
target phenotypes (e.g. better PCR ampliﬁcation eﬃciency
than catalytic eﬃciency) to increase in abundance at the
expense of those with target phenotypes. However, we
have used several general strategies to try and mitigate
the eﬀects of this scenario including: (i) conducting control
experiments under identical conditions; (ii) applying strin-
gent time pressure to favor the target phenotype; (iii) per-
forming extensive sequence analysis of each population at
two diﬀerent stages in the selection to minimize sampling
artifacts and (iv) determining the rates of both major and
minor sequence classes.
The practical utility of the deoxyribozymes described
herein is currently limited by their inability to cleave
all-RNA substrates as eﬀectively as the chimeric sub-
strates against which they were selected. Nevertheless,
these catalytic DNA molecules can potentially serve as
good starting points from which to evolve and/or engineer
improved activity against pyr–pyr junctions within all-
RNA substrates.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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